Recital 4, Regulation (EU) 2026/794

In forcesince 27 Mar 2026

Infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus are two very similar diseases from an epidemiological point of view, and they concern the same listed species. Both are vector-borne diseases with specific frequent testing requirements in the event that the diseases are reported during a period of at least 60 days prior to and during collection of the semen, oocytes or embryos in a Member State or zone thereof. Testing of semen donor animals of bovine, ovine and caprine species at semen collection centres for category D diseases other than infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus is mostly carried out at annual basis, while testing for infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus, if reported in a Member State or zone thereof, should be carried out at least every 7 or 28 days in the case an agent identification test is used, or in the period between 28 and 60 days from the date of each collection of the semen in the case a serological test is used. This fact, and the need to align the Union requirements to the WOAH recommendations, justify a different approach for those two diseases compared to other category D diseases to be introduced in Delegated Regulation (EU) 2020/686. Therefore, the requirement of no reported case of infection with bluetongue virus (serotypes 1-24) or infection with epizootic haemorrhagic disease virus in the establishment of origin, quarantine accommodation and semen collection centre for a period of at least 30 days prior to the date of collection of germinal products should be deleted and Articles 16 and 18 of Delegated Regulation (EU) 2020/686 should be amended accordingly.